eteraflex connects

Integrated Clinical Research & CRO Services for Global Clinical Development in India

eteraflex accelerates global clinical development in India by combining U.S. clinical governance with India’s extensive research ecosystem. Our integrated CRO solutions help biotechnology and medical device companies execute compliant, audit-ready, and cost-efficient clinical programs.

Why eteraflex Connects for Integrated CRO Services?

We simplify clinical research in India through integrated delivery, regulatory expertise, and 
technology-enabled execution, because of 4 cards:

US Clinical Governance + India Delivery

In-house FDA + DCGI regulatory, designed to EMA/PMDA/MFDS/NMPA 

Deep CDSCO & Subject Expert Committee experience 

Premier oncology sites & inspection-ready operations 

Integrated Clinical Solutions Built Around Your Program

Comprehensive strategy, regulatory, CMC, and operational capability — led by strategy, executed under one DCGI-registered CRO. 

01

Oncology — Strategy & Execution

Oncology development strategy and execution through premier Indian sites.

02

Regulatory Strategy 

(multi-region)

One plan across FDA, EMA, PMDA, MFDS, NMPA, DCGI.

03

CMC Advisory 

Manufacturing and quality strategy aligned to the filing. 

04

Clinical Operations 

end-to-end delivery under a DCGI-registered CRO, with enrollment acceleration.

05

Medical Writing

submission-ready documents for every agency.

06

India Market & Licensing
Strategy 

whether, when, and how to enter India.

07

FSP / FSO Clinical Science Pods 

embed expert capacity into your global program without losing control.

08

Commercial Foresight Engine 

will your asset win: access, competition, value across US & India.

How We Deliver Predictable Clinical Outcomes 

Discovery → Regulatory & CMC Strategy → Clinical Execution & Enrollment → Submission & Commercial Readiness 

Discovery

Regulatory Strategy

Clinical Execution

Submission & Commercial Readiness

The eteraflex Advantage

globe

Global Collaboration

US leadership with India-based operational excellence.

shield

Regulatory Excellence

in-house FDA + DCGI expertise with multi-region design. 

award

Quality Assurance 

 consistent, audit-ready execution across engagements. 

group

Operational Scale 

 premier oncology sites and experienced investigator networks. 

Performance Metrics

0 +

Years 
Experience

0 +

Research Sites

0 +

Clinical Professionals

0 +

Investigators

0 +

Regulatory Clearances

0 %

Approval Success

0 %

Inspection Pass Rate

Verticals We Serve

  • Oncology
  • Small & Mid-size Biotech
  • Medical Devices
  • Pharmaceuticals
  • Biologics 
  • Cell & gene therapy 
Scroll to Top